Heart Test Laboratories Inc (HSCS)
0.0888
-0.01
(-6.03%)
USD |
NASDAQ |
May 03, 16:00
0.0898
0.00 (0.00%)
After-Hours: 20:00
Heart Test Laboratories Enterprise Value: -0.7542M for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 03, 2024 | -0.7542M |
May 02, 2024 | -0.3805M |
May 01, 2024 | -0.5051M |
April 30, 2024 | -0.5182M |
April 29, 2024 | -0.256M |
April 26, 2024 | -0.1904M |
April 25, 2024 | -0.0265M |
April 24, 2024 | 0.498M |
April 23, 2024 | -0.0921M |
April 22, 2024 | -0.0265M |
April 19, 2024 | -0.0134M |
April 18, 2024 | 0.5373M |
April 17, 2024 | 0.0456M |
April 16, 2024 | 0.2423M |
April 15, 2024 | 0.1439M |
April 12, 2024 | 0.439M |
April 11, 2024 | 0.4324M |
April 10, 2024 | 0.7537M |
April 09, 2024 | 0.8127M |
April 08, 2024 | 0.5176M |
April 05, 2024 | 0.6094M |
April 04, 2024 | 0.4718M |
April 03, 2024 | 0.3537M |
April 02, 2024 | 0.2947M |
April 01, 2024 | 0.7406M |
Date | Value |
---|---|
March 28, 2024 | 1.088M |
March 27, 2024 | 1.101M |
March 26, 2024 | 1.285M |
March 25, 2024 | 1.291M |
March 22, 2024 | 1.291M |
March 21, 2024 | 1.265M |
March 20, 2024 | 1.586M |
March 19, 2024 | 1.750M |
March 18, 2024 | 1.422M |
March 15, 2024 | 1.730M |
March 14, 2024 | 1.619M |
March 13, 2024 | 1.126M |
March 12, 2024 | 1.041M |
March 11, 2024 | 1.276M |
March 08, 2024 | 1.354M |
March 07, 2024 | 1.647M |
March 06, 2024 | 1.895M |
March 05, 2024 | 5.094M |
March 04, 2024 | 2.045M |
March 01, 2024 | 1.334M |
February 29, 2024 | 1.113M |
February 28, 2024 | 1.009M |
February 27, 2024 | 1.223M |
February 26, 2024 | 0.8664M |
February 23, 2024 | 0.9809M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-0.7542M
Minimum
May 03 2024
27.59M
Maximum
Feb 03 2023
9.008M
Average
8.880M
Median
Enterprise Value Benchmarks
Ainos Inc | 10.28M |
OpGen Inc | 13.61M |
Zomedica Corp | 51.79M |
LENSAR Inc | 13.08M |
Eargo Inc (DELISTED) | -- |
Enterprise Value Related Metrics
Net Income (Quarterly) | -1.644M |
Revenue (Quarterly) | 0.0147M |
Total Expenses (Quarterly) | 1.540M |
EPS Diluted (Quarterly) | -0.03 |
Gross Profit Margin (Quarterly) | 68.97% |
Profit Margin (Quarterly) | -11.18K% |
Earnings Yield | -540.5% |
Normalized Earnings Yield | -540.54 |